BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 29, 2007
View Archived Issues
Serenex Raises $31M To Fund Mucositis And Hsp90 Programs
Serenex Inc. raised $31 million in Series D and debt funding to advance its lead compound for treating oral mucositis and the Hsp90 inhibitors behind that in the pipeline. (BioWorld Today)
Read More
Series D Adds $20M To Propel Koronis' Viral Extinction Drug
Read More
Chromosome Transplant "Huge Enabling Step" For Artificial Life
Read More
CombinatoRx Drops CRx-150, Favors CRx-102 In Arthritis
Read More
Other News To Note
Read More
Clinic Roundup
Read More